Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD

NCT04677465 is registered in ClinicalTrials.gov with Gala Therapeutics, Inc. as lead sponsor.

NCT NCT04677465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04677465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD
Lead sponsor
Gala Therapeutics, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
April 7, 2021
Completion date
October 31, 2025
Enrollment
270 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis